Larvol Delta - GSKs-investigational-liver-therapy-emosfermin-receives-US-FDA-Breakthrough-Therapy-and-EMA-Priority-Medicines-PRIME-designations-for-MASH

efimosfermin alfa (GSK6519754) - GSK

https://www.gsk.com/en-gb/media/press-releases/gsk-s-investigational-liver-therapy-efimosfermin-receives-us-fda-breakthrough-therapy/

Apr 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next